The CDC is recommending that Solgar ABC Dophilus Powder probiotic product should not be used following fatal gastronintestinal mucormycosis in an infant after use of the contaminated powder.
The FDA, CDC, and Connecticut Departments of Public Health and Consumer Protection are investigating a fatal case of gastrointestinal mucormycosis caused by Rhizopus oryzae in a premature infant in October. The infection followed the use of ABC Dophilus Powder, a probiotic purchased from Solgar, Inc., Leonia, NJ.
Testing of the same lot of unopened Solgar ABC Dophilus revealed contamination with Rhizopus oryzae, which may cause Mucormycosis.
The source of contamination is under investigation.
Solgar voluntarily recalled lots 074024-01R1, 074024-01, and 074024-02, expiration date July 31, 2015 on Nov. 14, 2014. The product was distributed domestically to 29 states and Puerto Rico, and was distributed internationally to the United Kingdom and Israel.
The distribution of the product has been suspended while FDA and the company continue to investigate the source of the problem.
